Background Neurofilament light chain (NfL) in cerebrospinal fluid (CSF) is a biomarker of
multiple sclerosis (MS). However, CSF sampling is invasive and has limited the clinical …

Neurofilament light chain (NfL) is a long-awaited blood biomarker that can provide clinically
useful information about prognosis and therapeutic efficacy in multiple sclerosis (MS). There …

Objective To assess the effects of demographics, lifestyle factors, and comorbidities on
serum neurofilament light chain (sNfL) levels in people without neurologic disease and …

Introduction Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, often
debilitating neuroinflammatory disease, whose predominant clinical manifestations are …

Multiple sclerosis (MS) is a chronic demyelinating and neuroinflammatory disease of the
human central nervous system with complex pathoetiology, heterogeneous presentations …

Objective To investigate relationships between serum neurofilament light chain (sNfL),
ubiquitin C-terminal hydrolase L1 (sUCHL1), tau (sTau) and glial fibrillary acidic protein …

Background: Serum neurofilament light (sNfL) chain is a promising biomarker reflecting
neuro-axonal injury in multiple sclerosis (MS). However, the ability of sNfL to predict …

Multiple sclerosis (MS) is an immune-mediated inflammatory and degenerative disorder of
the central nervous system (CNS) with heterogeneous clinical manifestations. In the last …

Minimizing the risk of relapse is essential in multiple sclerosis (MS). As none of the
treatments currently available are capable of completely preventing relapses, treatment of …

Background Optical coherence tomography angiography (OCT-A) is a novel technique
allowing non-invasive assessment of the retinal vasculature. During relapsing remitting …